UK markets open in 6 hours 50 minutes
NIKKEI 225
38,460.08 0.00 (0.00%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.65 -0.16 (-0.19%) GOLD FUTURES
2,327.70 -10.70 (-0.46%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,621.63 -1,826.17 (-3.42%)
Viking Therapeutics, Inc. (VKTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.16B |
| Enterprise value | 6.80B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 20.54 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -67.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | 232.12% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 99.41 |
| 52-week low 3 | 8.28 |
| 50-day moving average 3 | 65.84 |
| 200-day moving average 3 | 27.90 |
Share statistics
| Avg vol (3-month) 3 | 6.46M |
| Avg vol (10-day) 3 | 2.28M |
| Shares outstanding 5 | 110.22M |
| Implied shares outstanding 6 | 110.22M |
| Float 8 | 95.04M |
| % held by insiders 1 | 6.03% |
| % held by institutions 1 | 71.57% |
| Shares short (28 Mar 2024) 4 | 9.52M |
| Short ratio (28 Mar 2024) 4 | 0.97 |
| Short % of float (28 Mar 2024) 4 | 11.65% |
| Short % of shares outstanding (28 Mar 2024) 4 | 8.64% |
| Shares short (prior month 29 Feb 2024) 4 | 12.28M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -23.47% |
| Return on equity (ttm) | -34.79% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -85.89M |
| Diluted EPS (ttm) | -0.91 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 362.08M |
| Total cash per share (mrq) | 3.6 |
| Total debt (mrq) | 1.26M |
| Total debt/equity (mrq) | 0.36% |
| Current ratio (mrq) | 19.19 |
| Book value per share (mrq) | 3.48 |
Cash flow statement
| Operating cash flow (ttm) | -73.38M |
| Levered free cash flow (ttm) | -42.36M |
© 2024 Yahoo. All rights reserved.